Back to search
FDAFDA · Food and drugs·Recall number D-1324-2022

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

Published August 17, 2022 · Recall initiated: June 29, 2022

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: products were stored outside the drug label specifications.

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
Mckesson Medical-Surgical Inc. Corporate Office
Distributor
Nationwide in the USA.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card